NCT06928155

Brief Summary

The project explores the use of virtual reality (VR) as a tool to improve the quality of life of people with dependence, providing immersive and personalized environments that support physical, neurological and psychological rehabilitation. VR makes it possible to practice complex movements, improve strength and coordination, reduce stress and anxiety, and enhance brain plasticity through adapted simulations that are also motivating and safe for users. This approach facilitates more effective rehabilitation than traditional therapies by allowing repetition and visualization of movements that are difficult to perform in real life. The El Saliente Association, in collaboration with the University of Almeria, leads this initiative that seeks to promote the autonomy, inclusion and emotional well-being of people with dependence. With specific objectives such as improving motor function, stimulating neuroplasticity, reducing pain through immersive distraction and enhancing independence, the project uses VR sessions in controlled environments. In addition, activities that simulate everyday situations will be designed to facilitate the transfer of acquired skills to the real environment. The work plan is divided into design, development, implementation and analysis phases, including participant selection, software development, pilot testing and evaluation of results. At each stage, data will be collected to measure the effectiveness of the intervention, with the ultimate goal of publishing the findings in scientific forums and replicating the experience in other contexts. Day center facilities and a residential complex will provide the necessary spaces and materials to carry out the interventions. Expected outcomes include increased motivation and adherence to therapy, faster functional recovery and an overall improvement in quality of life, including increased self-esteem and reduced anxiety. This project promises a significant advance in the use of technology for inclusive rehabilitation, with benefits not only for patients but also for the advancement of innovative therapeutic solutions in the field of dependency.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
172

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 15, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 28, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2025

Completed
Last Updated

July 29, 2025

Status Verified

July 1, 2025

Enrollment Period

5 months

First QC Date

April 7, 2025

Last Update Submit

July 28, 2025

Conditions

Keywords

quality of life, dependency, virtual reality, rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Anxiety levels

    Anxiety levels will be measured using the Generalized Anxiety Disorder (GAD-7).

    At baseline, at 6 weeks and at 2 months.

Secondary Outcomes (6)

  • Adherence levels

    At baseline, at 6 weeks and at 2 months

  • Functional mobility

    At baseline, at 6 weeks and at 2 months

  • Ability to perform activities of daily living

    At baseline, at 6 weeks and at 2 months

  • Cognitive impairment

    At baseline, at 6 weeks and at 2 months

  • Usability/Acceptability

    At 6 weeks and at 2 months

  • +1 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

The intervention group will receive immersive virtual reality sessions twice a week, for a total of 6 weeks, with sessions lasting no more than 30 minutes.

Device: Immersive Virtual Reality with Head Mounted Display

Control group

ACTIVE COMPARATOR

The control group will continue with their usual physiotherapy treatment, which includes aerobic exercises and strength training.

Other: Aerobic exercise and strength training

Interventions

The intervention will be carried out with an immersive virtual reality device, specifically, with a head mounted display. Specifically, it is the "MetaQuest 3" model.

Intervention group

The combination of aerobic and strength training is part of the conventional physiotherapy treatment carried out at the center.

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over 18 years of age
  • Patients who agree to participate in the study and sign the informed consent form.

You may not qualify if:

  • Those with severe visual impairment, vertigo, epilepsy or psychosis, and who may interfere with the normal performance of interactive voice response (IVR) tasks, will be excluded as a precaution.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asociación "El Saliente"

Almería, Andalusia, 04007, Spain

RECRUITING

MeSH Terms

Interventions

Smart GlassesExerciseResistance Training

Intervention Hierarchy (Ancestors)

Wearable Electronic DevicesElectrical Equipment and SuppliesEquipment and SuppliesMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, Human

Central Study Contacts

Raúl Romero del Rey, Doctor of Physiotherapy

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.D.

Study Record Dates

First Submitted

April 7, 2025

First Posted

April 15, 2025

Study Start

June 1, 2025

Primary Completion

October 28, 2025

Study Completion

December 28, 2025

Last Updated

July 29, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations